A detailed history of Itau Unibanco Holding S.A. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Itau Unibanco Holding S.A. holds 153 shares of VRTX stock, worth $62,451. This represents 0.0% of its overall portfolio holdings.

Number of Shares
153
Previous 164 6.71%
Holding current value
$62,451
Previous $76,000 6.58%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$460.0 - $505.78 $5,060 - $5,563
-11 Reduced 6.71%
153 $71,000
Q2 2024

Aug 13, 2024

BUY
$392.81 - $485.53 $64,420 - $79,626
164 New
164 $76,000
Q4 2023

Feb 14, 2024

SELL
$343.0 - $410.68 $145,432 - $174,128
-424 Reduced 56.01%
333 $135,000
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $256,002 - $274,382
757 New
757 $263,000
Q4 2022

Feb 09, 2023

BUY
$285.76 - $321.48 $561,518 - $631,708
1,965 New
1,965 $567,000
Q1 2022

May 16, 2022

SELL
$221.42 - $260.97 $202,377 - $238,526
-914 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $39,827 - $50,276
225 Added 32.66%
914 $203,000
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $17,594 - $19,690
97 Added 16.39%
689 $125,000
Q2 2021

Aug 17, 2021

BUY
$187.49 - $221.1 $110,994 - $130,891
592 New
592 $119,000
Q1 2020

May 15, 2020

SELL
$199.77 - $247.81 $51,340 - $63,687
-257 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $11,669 - $15,673
-70 Reduced 21.41%
257 $56,000
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $53,827 - $62,250
327 New
327 $60,000
Q2 2018

Aug 13, 2018

SELL
$145.72 - $169.96 $403,790 - $470,959
-2,771 Closed
0 $0
Q1 2018

May 14, 2018

SELL
$151.6 - $177.13 $475,569 - $555,656
-3,137 Reduced 53.1%
2,771 $452,000
Q4 2017

Feb 09, 2018

BUY
$137.28 - $155.55 $383,148 - $434,140
2,791 Added 89.54%
5,908 $885,000
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $461,721 - $505,702
3,117
3,117 $1.5 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.